RECRUITING
I'm interested ...!!
Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE
The PREVUE-VALVE study will establish reliable, population-based estimates of Valvular Heart Disease (VHD) prevalence among older Americans and allow for the development and validation of several innovative tools to aid in the detection and diagnosis of Valvular Heart Disease (VHD).
Conditions:
🦠 Valvular Heart Disease
🗓️ Study Start (Actual) 21 April 2022
🗓️ Primary Completion (Estimated) April 2025
✅ Study Completion (Estimated) April 2025
👥 Enrollment (Estimated) 2250
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Lafayette, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age 65-85
    • * Ability to provide informed consent
    • * Stably domiciled in a residence that can be accessed by study personnel

    Exclusion Criteria:

    • * History of complex congenital heart disease
Ages Eligible for Study: 65 Years to 85 Years (OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 24 April 2022
  • First Submitted that Met QC Criteria 28 April 2022
  • First Posted 2 May 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 11 December 2023
  • Last Update Posted 15 December 2023
  • Last Verified December 2023
I'm interested ...!!